Immunosuppressants: frequent therapeutic concentration monitoring of immunosuppresant levels is recommended until levels have stabilised as plasma concentrations of cyclosporin, rapamycin and tacrolimus may be increased when co-administered with fosamprenavir with ritonavir.
Hyppig koncentrationsmåling af immunosuppressanten anbefales indtil niveauet er stabiliseret, idet plasmakoncentrationen af cyklosporin, rapamycin og tacrolimus kan være forhøjet, når stofferne administreres sammen med fosamprenavir og ritonavir.